Navigation Links
According to AlphaDetail, Inc. Merck and Tibotec Therapeutics Lead Among Infectious Disease Specialists
Date:11/5/2008

SAN MATEO, Calif., Nov. 5 /PRNewswire/ -- In a survey of 100 infectious disease specialists following last week's ICAAC/IDSA Annual Meeting, Merck was perceived as standing out above other companies at the conference, while Tibotec Therapeutics was perceived as having the best overall image in infectious disease. GlaxoSmithKline, Pfizer and Cubist Pharmaceuticals rounded out the top companies in overall image among the specialists.

The 2008 ICAAC/IDSA Annual meeting -- one of the largest meetings attended by infectious disease specialists -- was held from October 25-28 in Washington D.C. AlphaDetail conducted a brief AlphaPulse(TM) survey of 100 infectious disease specialists to gauge physician reaction to data presented at the meeting. Of the respondents, half attended the 2008 meeting.

When asked their opinion about what the most important data presented at this year's conference was, nearly half of the respondents cited topics focused on HIV, particularly findings in initiating earlier treatment, the approval of a new dosing regimen for Prezista in naive patients, and data about newer HIV treatments showing promise as 1st line therapies. New MRSA data was also cited frequently.

"There was new data presented on HIV treatment regarding use of either

Prezista or raltegravir as first-line agents".

-- Infectious Disease Specialist, 11/08

When prompted with data presented at the conference, the majority of respondents revealed that the most important study indicated a 70% improvement in survival for patients who initiated HAART therapy with CD4 counts between 351 and 500 vs. those who initiated at 350 and below. Interestingly, a large percentage of respondents also highlighted key findings about a compound (TMC207) as important news that they were not familiar with prior to the meeting.

To receive the full AlphaPulse(TM) report at no charge, please contact Bob Latshaw at (215) 259-5601.

About AlphaDetail, Inc.:

At AlphaDetail, we have an unparalleled commitment to our clients. We are a full-service primary market research firm, with a particular emphasis in large and complex quantitative studies for the global healthcare community. AlphaDetail is built on one of the industry's strongest foundations that includes a large team of exceptional analytical specialists, the industry's leading technology platform and a flexible approach to research that helps us to answer our client's most challenging questions.

Footnotes:

The 48th Annual Interscience Conference on Antimicrobial Agents and

Chemotherapy (ICAAC) and 46th Annual Infectious Disease Society of America

(IDSA) meeting was held from October 25-28 in Washington DC.


'/>"/>
SOURCE AlphaDetail, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Global Agricultural and Environmental Diagnostics Market to Reach $2.4 Billion by 2012, According to New Report by Global Industry Analysts
2. World Gene Amplification Technologies Market to Reach $2.2 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
3. World Gene Therapy Market to Reach $484 Million by 2015, According to New Report by Global Industry Analysts, Inc.
4. Global Drug Discovery Technologies Market to Exceed $57 Billion by 2012, According to a New Report by Global Industry Analysts
5. Biomoda, Inc. (BMOD) SqueezeTrigger Price is $0.27. Approximately 1 Million Shares Shorted Since November 2006 According to Buyins.net Research Report
6. Microplate Instrumentation & Supplies Market to Exceed $5.0 Billion by 2015, According to New Report by Global Industry Analysts, Inc
7. Genetic Testing Market to Exceed $6.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
8. Titrators Market to Reach $315 Million by 2015, According to New Report by Global Industry Analysts, Inc.
9. Laboratory Pumping Systems to Reach $3.1 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
10. Innovation and Strong Therapeutic Potential Seen in Adult Stem Cells, According to Frost & Sullivan
11. New Bill to Expand Promotion of Biofuels Is a Welcome Boost for U.S.-Brazil Relations According to Brazilian Sugarcane Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... March 24, 2017 On Thursday, ... session at 5,817.69, down 0.07%; the Dow Jones Industrial ... the S&P 500 closed at 2,345.96, marginally dropping 0.11%. ... closed in green, 4 sectors finished in red, and ... Stock-Callers.com has initiated reports coverage on the following Biotechnology ...
(Date:3/24/2017)... 24, 2017 Agenus Inc. (NASDAQ: AGEN), an ... and cancer vaccines, today announced participation at the following ... William Blair and Maidstone Life Sciences conference "Cancer Immunotherapy ... New York, NY . Agenus will ... at 9:40 am: Robert B. Stein , M.D., ...
(Date:3/23/2017)... ... ... Lajollacooks4u is proud to announce it has become the premiere team-building cooking event company in ... the world, such as Illumina, HP and Qualcomm, and is ranked #1 in its category ... due to its new team building format, a way for teams to not only interact ...
(Date:3/23/2017)... 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW ... therapies for solid tumor cancers, today announced that ... it announced last Friday, March 17, 2017. ... investors securities totaling 28,843,692 shares, comprised of 18,843,692 ... shares of Class C Warrants pre-funded at the ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/27/2017)...   Strategic Cyber Ventures , the industry,s first ... $3.5 million investment in  Polarity , the first commercial ... DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran and ... series A round of funding. This new funding will ...
(Date:2/21/2017)... -- Der weltweite Biobanking-Sektor wird bis zum ... mit mehr als 50 Vertretern aus verschiedenen Branchen wurde aber ... diese Prognose zu realisieren. ... Zu den Schwierigkeiten für ... für die Biobank, die Implementierung Zeit sparender Technologien, ein ...
Breaking Biology News(10 mins):